1. Home
  2. ACET vs AP Comparison

ACET vs AP Comparison

Compare ACET & AP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Adicet Bio Inc.

ACET

Adicet Bio Inc.

N/A

Current Price

$7.47

Market Cap

69.6M

Sector

Health Care

ML Signal

N/A

Logo Ampco-Pittsburgh Corporation

AP

Ampco-Pittsburgh Corporation

N/A

Current Price

$9.52

Market Cap

138.0M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
ACET
AP
Founded
1947
1929
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Fluid Controls
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
69.6M
138.0M
IPO Year
2017
N/A

Fundamental Metrics

Financial Performance
Metric
ACET
AP
Price
$7.47
$9.52
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$65.33
N/A
AVG Volume (30 Days)
140.1K
289.9K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
59.82
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.45
$1.75
52 Week High
$9.05
$9.97

Technical Indicators

Market Signals
Indicator
ACET
AP
Relative Strength Index (RSI) 52.48 61.62
Support Level $6.54 $2.39
Resistance Level $8.46 $9.69
Average True Range (ATR) 0.46 0.72
MACD -0.01 -0.06
Stochastic Oscillator 49.12 78.49

Price Performance

Historical Comparison
ACET
AP

About ACET Adicet Bio Inc.

Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Its product candidate, ADI-001, a first-in-class allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, is being developed for the potential treatment of autoimmune diseases and relapsed or refractory aggressive B cell non-Hodgkin's lymphoma. Their pipeline also includes its preclinical candidate, ADI-270, an armored gamma delta CAR T cell product candidate targeting renal cell carcinoma, with potential for other CD70+ solid tumor and hematological malignancies indications.

About AP Ampco-Pittsburgh Corporation

Ampco-Pittsburgh Corp is manufacturing and selling engineered, specialty metal products and customized equipment. It operates in two business segments namely the Forged and Cast Engineered Products segment and the Air and Liquid Processing segment. The Forged and Cast Engineered Products segment produces forged hardened steel rolls, cast rolls, and open-die forged products. Forged hardened steel rolls are used in cold rolling mills by producers of steel, aluminum, and other metals whereas, the Air and Liquid Processing segment includes Aerofin, Buffalo Air Handling, and Buffalo Pumps. The company generates a majority of its revenue from the Forged and Cast Engineered Products segment. It has a business presence in the United States and other countries.

Share on Social Networks: